AMRX - CIK 0001723128
Amneal Pharmaceuticals, Inc. has filed 664 documents with the SEC between 2017 and 2026. The most frequent type is insider trade (297 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G | - | 2024-10-30 | - |
| Major company event | 8-K | 2024-10-01 | 2024-10-01 |
| Insider trade | 4 | 2024-08-16 | 2024-08-14 |
| Insider trade | 4 | 2024-08-16 | 2024-08-14 |
| Insider sale notice | 144 | 2024-08-14 | - |
| Insider sale notice | 144 | 2024-08-14 | - |
| Insider sale notice | 144 | 2024-08-14 | - |
| Quarterly report | 10-Q | 2024-08-09 | 2024-06-30 |
| Major company event | 8-K | 2024-08-09 | 2024-08-07 |
| Insider trade | 4 | 2024-05-20 | 2024-05-16 |
| Insider sale notice | 144 | 2024-05-16 | - |
| Insider trade | 4 | 2024-05-14 | 2024-05-10 |
| Insider trade | 4 | 2024-05-14 | 2024-05-10 |
| Insider trade | 4 | 2024-05-14 | 2024-05-10 |
| Insider trade | 4 | 2024-05-14 | 2024-05-10 |
| Insider trade | 4 | 2024-05-14 | 2024-05-10 |
| Insider trade | 4 | 2024-05-14 | 2024-05-10 |
| Insider trade | 4 | 2024-05-14 | 2024-05-10 |
| Insider trade | 4 | 2024-05-14 | 2024-05-10 |
| Insider trade | 4 | 2024-05-14 | 2024-05-10 |
| Activist ownership stake (update) | SC 13D/A | 2024-05-13 | - |
| Quarterly report | 10-Q | 2024-05-08 | 2024-03-31 |
| Major company event | 8-K | 2024-05-07 | 2024-05-02 |
| Insider trade | 4 | 2024-05-06 | 2024-05-02 |
| Insider trade | 4 | 2024-05-06 | 2024-05-02 |
| Insider trade | 4 | 2024-05-06 | 2024-05-02 |
| Insider trade | 4 | 2024-05-06 | 2024-05-02 |
| Insider trade | 4 | 2024-05-06 | 2024-05-02 |
| Insider trade | 4 | 2024-05-06 | 2024-05-02 |
| Insider trade | 4 | 2024-05-06 | 2024-05-02 |
| Insider trade | 4 | 2024-05-06 | 2024-05-02 |
| Insider trade | 4 | 2024-05-06 | 2024-05-02 |
| Major company event | 8-K | 2024-05-03 | 2024-05-03 |
| Passive ownership stake (update) | SC 13G/A | 2024-04-24 | - |
| Proxy materials | DEFA14A | 2024-03-22 | - |
| Proxy statement | DEF 14A | 2024-03-22 | 2024-05-02 |
| Annual report | 10-K | 2024-03-14 | 2023-12-31 |
| Insider trade | 4 | 2024-03-14 | 2024-03-12 |
| Insider trade | 4 | 2024-03-06 | 2024-03-04 |
| Insider trade | 4 | 2024-03-06 | 2024-03-04 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-03 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Insider trade | 4 | 2024-03-05 | 2024-03-01 |
| Major company event | 8-K | 2024-03-01 | 2024-03-01 |
| Insider trade | 4 | 2024-02-29 | 2024-02-27 |
| Insider trade | 4 | 2024-02-29 | 2024-02-27 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-13 | - |
| Major company event | 8-K | 2024-01-10 | 2024-01-10 |
| Passive ownership stake | SC 13G | 2024-01-05 | - |